Invictus MD Strategies Corp (IVITF)

[OD3]

VANCOUVER, Jan. 21, 2019 /CNW/ - INVICTUS MD STRATEGIES CORP. ("Invictus" or the "Company") (TSXV: GENE; OTCQX: IVITF; FRA: 8IS1) is pleased to announce that the Company's wholly-owned subsidiary 0989561 B.C. Ltd. ("Canandia") has received a sales license for its Delta location (the "Delta Facility") from Health Canada effective January 18, 2019, pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). The Delta Facility includes a cultivation, production and research facility, designed to highlight our capabilities as producers and breeders of superior cannabis strains.

Canandia's second asset is located in Mission (the "Mission Location"), British Columbia. The Mission Location includes 32 acres of buildable land, expandable up to 1 million square feet of production capacity under one Cannabis Act and Cannabis Regulations license. The Mission Location taps into wholesale energy costs with 38 MG Watt service at the property line, and boasts access to underground aquifers, making it a strategically attractive and cost competitive addition to Invictus' current cultivation footprint once developed and commissioned.